Skandiabanken ASA : Continued profitable growth

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
59
Skandiabanken ASA : Continued profitable growth

Bergen, 9 February 2017: The Skandiabanken group increased its net profit to NOK 149.7 million in the fourth quarter of 2016, compared to NOK 106.0 million last year. The increase in profit was primarily a result of strong growth in customer lending and increased net interest margin. At year end, total customer lending was NOK 63.5 billion, compared to NOK 56.9 billion at year end 2015, corresponding to an annual growth rate of 11.6 per cent. The net interest margin in the quarter increased to 1.74 per cent from 1.59 per cent in the fourth quarter of 2015. Return on equity was 12.7 per cent compared to 12.1 per cent in the fourth quarter of last year

Highlights (corresponding period last year in parentheses):

  • Net interest margin increased to 1.74 (1.59) per cent
  • Strong growth in lending to customers - 11.6 per cent previous 12 months
  • Net interest income increased by 18.8 per cent to NOK 309.3 (260.3) million
  • Net fee and commission income NOK 42.1 (32.4) million
  • Low loan losses - loss rate of 0.09 (0.06) per cent
  • Solid capitalisation - CET1 of 14.9 per cent

 "Financially we have delivered another strong quarter with a return on equity of 12.7 per cent. Skandiabanken has the most satisfied bank customers in Norway and an annual growth rate of 11.6 per cent confirms that our popularity increases. Our strong capital position, user friendly services, fair and transparent prices support future growth." says Magnar Øyhovden, CEO of Skandiabanken ASA.

Net interest income improved to NOK 309.3 (260.3) million, as a result of increased net lending to customers and a higher net interest margin.

Operating expenses were NOK 140.7 (144.0) million in the quarter. Adjusted for one-off costs of NOK 5.1 million, operating expenses in the quarter were NOK 135.6 million, and thus in line with the previous quarters.

The net cost of losses in the quarter was NOK 13.6 (9.1) million and the loan-loss rate was 0.09 (0.06). At the end of the quarter, the bank had recorded total write-downs of NOK 148.4 million, compared to NOK 135.0 million at the end of the third quarter of 2016.

At the end of the quarter, the bank had a core Tier 1 capital ratio of 14.9 per cent, a Tier 1 capital ratio of 16.3 per cent and a total capital ratio amounting to 18.0 per cent. At quarter-end Skandiabanken had a leverage ratio of 6.3 per cent, up from 6.1 per cent in the third quarter of 2016.

The process of replacing the remaining service agreements with the Swedish Skandia Group with new third party agreements was completed in the quarter within planned time and cost.

A detailed financial report for the group and for Skandiabanken ASA is attached to this notice. The report for the wholly owned subsidiary, Skandiabanken Boligkreditt AS, is distributed separately.

Contact details, Investor Relations Brede Selseng, Head of IR Skandiabanken ASA, +47 971 62 171 Henning Nordgulen, CFO, Skandiabanken ASA, +47 952 65 990

Media contact Ole Bernhard Larsen, Chief Communication Officer, Skandiabanken ASA, +47 959 40 045

About Skandiabanken ASA In April 2000, Skandiabanken was launched as the first purely digital bank in Norway. Today, the Bank offers a comprehensive range of financial products and services to individuals and households in Norway within payments and card services, deposit-based savings, investment products, long-term loans and short- term loans. The Bank has no branches and all products and services are offered directly through the digital platform, which is available on a broad range of user devices. As of 31 December 2016, Skandiabanken had 390 000 active customers and total assets of NOK 71.2 billion. For more information, see skandiabanken.no/investor-relations.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...ce6f39b75e

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...f4783311a7

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Securitize's Bold Move: Venturing into Asset-backed Lending

Updated Category News Views 48

Jumping into the Big League Securitize Corp. is shaking things up with its latest strategic move to acquire River One, an asset-backed financing firm. Now, this ain't just another run-of-the-mill acquisition to throw in the pile—it positions Securitize to plunge into the massive $6 trillion private asset-backed finance market. That's the kind of hefty expansion that...

Continue Reading
NSAP's First Board Aims to Revolutionize Autism Care

Updated Category News Views 11

Out in Silicon Valley, where innovation isn’t just a buzzword, the National Society of Autism Professionals (NSAP) is stirring the pot with some serious leadership moves. Just this month, they cobbled together their inaugural board of directors—a gathering of eight experts from every corner of the autism field you can think of. They’re not playing small ball, no...

Continue Reading
Credit Union Teams Up for Holiday Toy Drive in San Diego

Updated Category News Views 70

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

Continue Reading
Ex-Special Ops Leader Fenton Joins SAGINT's Advisory Board

Updated Category News Views 22

If you’ve been around long enough, you know that in defense, the game’s all about who you know and how you move. And in this arena, General Bryan P. Fenton doesn’t just walk in—he bursts through the darn doors with gravitas honed by years commanding folks who live by grit and sinew. His latest move? Clambering aboard the SAGINT® Board of Advisors, ready to tackle...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 279

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 75

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading
Illinois Ban Risks Boosting Illicit THC Drink Sales

Updated Category News Views 61

Illinois Cranks Up the Heat on Low-Dose THC Drinks Illinois, you've really done it this time. When it comes to low-dose THC beverages, the state is setting up shop for illicit sellers by going harsher than federal standards. On November 12, these drinks, which have a loyal following, will be off the shelves—thanks to a reclassification that lumps them in with more...

Continue Reading
Celebrating Science with Southeastern Tile's Sponsorship

Updated Category News Views 65

Crafting Pathways and Fostering Curiosity In this world of rapid change and relentless innovation, supporting education—especially in science and technology—is like buying a piece of the future. And, boy, is Southeastern Tile Connection onto something with that. They've stepped up as an Exploration Sponsor for the Asheville Museum of Science's (AMOS) annual gala,...

Continue Reading
Ionis Faces Legal Scrutiny Amid Slashed Sales Forecast

Updated Category News Views 57

Ionis Pharmaceuticals Takes a Hit: What's Happening? November 9, 2026, wasn't just another dreary market day—especially if you've got a stake in Ionis Pharmaceuticals. Today, they whittled down their full-year sales forecast for TRYNGOLZA from a cozy $100 million to $110 million range to a startling $50 million. NASDAQ: IONS shares naturally took a nosedive, and as...

Continue Reading
Blurry Vision Explained: Beyond Just a Lens Issue

Updated Category News Views 69

Why Your Vision Might Be Blurry: It's Not Always Simple Dr. Spencer Franz isn’t just another face behind an optometry chart. He’s tackling a topic as blurry as it is relatable—your vision. You'd think a simple tweak of your glasses script might do the trick, but surprise, surprise, vision issues are sneakier than that. Changes in prescriptions are a dime a dozen,...

Continue Reading

Top 5 Most Recently Viewed Articles

Euroseas Ltd. Gains Momentum with New Charter for M/V Jonathan P

Updated Category News Views 35

New Charter Contract for M/V Jonathan P Euroseas Ltd. (NASDAQ: ESEA), an esteemed player in the container shipping industry, proudly announces the establishment of a time charter contract for its 1,732 TEU feeder containership, M/V Jonathan P. This contract spans a minimum of 11 months and may extend to a maximum of 13 months at a favorable gross daily rate of $20,000....

Continue Reading
An In-depth Comparison of Micron Technology in the Chip Sector

Updated Category News Views 568

Understanding Micron Technology's Position in the Semiconductor Industry In the dynamic world of semiconductors, evaluating a company effectively is vital for investors looking to make educated decisions. This article provides a thorough comparison of Micron Technology (NASDAQ: MU) against its competitors, shedding light on essential financial metrics and growth...

Continue Reading
Abbott's Oncodetect Test: Game-Changer for Cancer Recurrence

Updated Category News Views 70

Pioneering Progress in Colorectal Cancer Detection There's a new player in the world of cancer diagnostics, and it's setting a fresh standard. Abbott's Oncodetect test, featured at the ESMO Congress, has shown a profound leap in sensitivity—30 percent over the older whole-exome sequencing approach. For those doing the math on the stock charts, Abbott (NYSE: ABT) is...

Continue Reading
Marvell Technology Reports Impressive Q3 Earnings Growth

Updated Category News Views 269

Marvell Technology Posts Strong Q3 Earnings Marvell Technology Inc. (NASDAQ: MRVL) delivered an impressive financial performance for the third quarter, significantly surpassing market expectations. The company reported quarterly adjusted earnings of 76 cents per share, outperforming the analyst estimate of 73 cents, according to recent analytical reports. With quarterly...

Continue Reading
OkayCoin Launches Free Trial Staking for New Crypto Investors

Updated Category News Views 54

Introducing OkayCoin's Revolutionary Free Trial Liquid Staking OkayCoin has made an exciting move in the cryptocurrency sector by introducing a new Free Trial Liquid Staking program aimed at welcoming new investors. This innovative solution allows newcomers to experience the world of crypto staking with a minimal investment of just $100, providing an accessible entry...

Continue Reading